Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,092 | 298 | 99.4% |
| Education | $18.08 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $550.24 | 11 | $0 (2020) |
| GlaxoSmithKline, LLC. | $532.81 | 109 | $0 (2019) |
| PFIZER INC. | $529.18 | 55 | $0 (2020) |
| Novo Nordisk Inc | $257.66 | 21 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $225.76 | 24 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $212.27 | 23 | $0 (2019) |
| Amgen Inc. | $170.16 | 9 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $137.87 | 10 | $0 (2019) |
| Lilly USA, LLC | $123.43 | 10 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $102.26 | 8 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $69.06 | 1 | Novo Nordisk Inc ($69.06) |
| 2021 | $19.80 | 1 | Astellas Pharma US Inc ($19.80) |
| 2020 | $100.83 | 7 | PFIZER INC. ($42.30) |
| 2019 | $917.89 | 109 | PFIZER INC. ($211.01) |
| 2018 | $1,081 | 97 | AstraZeneca Pharmaceuticals LP ($248.87) |
| 2017 | $921.76 | 86 | GlaxoSmithKline, LLC. ($227.02) |
All Payment Transactions
301 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $69.06 | General |
| Category: Diabetes | ||||||
| 08/19/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: UROLOGY | ||||||
| 03/12/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/24/2020 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: DERMATOLOGY | ||||||
| 02/20/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Endocrinology | ||||||
| 02/19/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/03/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Diabetes | ||||||
| 01/29/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/07/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/05/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/05/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/04/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.05 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: DIABETES | ||||||
| 10/30/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/30/2019 | PFIZER INC. | EUCRISA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,238 | 4,676 | $626,389 | $127,456 |
| 2022 | 38 | 1,692 | 3,941 | $705,171 | $146,069 |
| 2021 | 39 | 3,061 | 5,570 | $716,057 | $172,146 |
| 2020 | 25 | 1,344 | 4,177 | $654,319 | $130,320 |
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 322 | 550 | $159,500 | $42,198 | 26.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 20 | 1,860 | $232,607 | $33,814 | 14.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 285 | 488 | $97,112 | $26,385 | 27.2% |
| 77067 | Screening mammography | Office | 2023 | 70 | 70 | $27,162 | $6,515 | 24.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 55 | 55 | $4,125 | $3,953 | 95.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 52 | 82 | $17,958 | $2,710 | 15.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 46 | 51 | $7,140 | $2,071 | 29.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 60 | 61 | $2,440 | $1,844 | 75.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 23 | 40 | $14,840 | $1,838 | 12.4% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 69 | 69 | $7,791 | $1,673 | 21.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 31 | 40 | $12,360 | $1,669 | 13.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 53 | 63 | $16,152 | $889.33 | 5.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 38 | $6,536 | $424.08 | 6.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 18 | 37 | $2,976 | $319.75 | 10.7% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 13 | 16 | $4,004 | $305.28 | 7.6% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 13 | 13 | $3,029 | $205.90 | 6.8% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 44 | 47 | $5,507 | $194.22 | 3.5% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 13 | 13 | $1,742 | $185.70 | 10.7% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 15 | 15 | $2,340 | $144.68 | 6.2% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 14 | 1,068 | $1,068 | $115.92 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 315 | 512 | $144,384 | $37,594 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 291 | 523 | $100,939 | $28,234 | 28.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 17 | 1,620 | $196,322 | $26,977 | 13.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 76 | 148 | $46,176 | $8,812 | 19.1% |
| 77067 | Screening mammography | Office | 2022 | 75 | 78 | $28,554 | $7,296 | 25.5% |
About Dr. Mark Olson, MD
Dr. Mark Olson, MD is a Family Medicine healthcare provider based in Williston, North Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023182110.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Olson, MD has received a total of $3,111 in payments from pharmaceutical and medical device companies, with $69.06 received in 2022. These payments were reported across 301 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,092).
As a Medicare-enrolled provider, Olson has provided services to 7,335 Medicare beneficiaries, totaling 18,364 services with total Medicare billing of $575,991. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Williston, ND
- Active Since 11/20/2006
- Last Updated 04/29/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1023182110
Products in Payments
- FARXIGA (Drug) $457.35
- ELIQUIS (Drug) $320.98
- ANORO (Drug) $261.64
- Trintellix (Drug) $241.25
- ENTRESTO (Drug) $137.87
- Prolia (Biological) $118.98
- EUCRISA (Drug) $111.23
- TRADJENTA (Drug) $100.16
- SYMBICORT (Drug) $92.89
- XARELTO (Drug) $91.50
- Victoza (Drug) $91.48
- Ozempic (Drug) $78.87
- Rybelsus (Drug) $69.06
- Myrbetriq (Drug) $68.20
- TRELEGY ELLIPTA (Drug) $62.99
- LYRICA (Drug) $57.01
- TRULICITY (Drug) $51.42
- NUCALA (Biological) $50.99
- VRAYLAR (Drug) $48.04
- CHANTIX (Drug) $47.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Williston
William Small, Md, MD
Family Medicine — Payments: $1,636
Ryan Siewert, Md, MD
Family Medicine — Payments: $1,249
Dr. Kolli Reddy, Md, MD
Family Medicine — Payments: $294.53
James Kennedy, Md, MD
Family Medicine — Payments: $88.88
Stephen Mann, Md, MD
Family Medicine — Payments: $43.52
Pratibha Lumb, M.d, M.D
Family Medicine — Payments: $35.81